Board of Trustees of The Leland Stanford Junior University’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-9,045	Closed	-$255K	–	33
2019 Q3	$255K	Hold	9,045	–	–	0.03%	25
2019 Q2	$300K	Hold	9,045	–	–	0.04%	23
2019 Q1	$308K	Hold	9,045	–	–	0.04%	20
2018 Q4	$248K	Buy	+9,045	New	+$233K	0.03%	20

Other funds holding PRNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's PRNB Position: Q4 2019 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q4 2019, closing a stake of 9,045 shares — an estimated $255K sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in PRNB in Q4 2018 and held it in 4 quarters. The position peaked at $308K in Q1 2019. 115 funds tracked by Wall St. Rank hold PRNB as of Q4 2019.

Board of Trustees of The Leland Stanford Junior University reported no remaining Principia Biopharma Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 9,045 Principia Biopharma Inc. Common Stock shares in Q4 2019, an estimated $255K.
Board of Trustees of The Leland Stanford Junior University first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 4 quarters.
Board of Trustees of The Leland Stanford Junior University's Principia Biopharma Inc. Common Stock position peaked at $308K in Q1 2019.
115 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q4 2019.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q4 2019, filed 12 Feb 2020.